The evolution of commercial drug delivery technologies

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139 · see citing works

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592 · see citing works

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,484 · see citing works

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119 · see citing works

RNA-Guided Human Genome Engineering via Cas9

Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · see citing works

Stimuli-responsive nanocarriers for drug delivery

Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289 · see citing works

Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia

Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735 · see citing works

Liposomal drug delivery systems: From concept to clinical applications

Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · see citing works

Doxil® — The first FDA-approved nano-drug: Lessons learned

Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · see citing works

Drug Delivery Systems: Entering the Mainstream

Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552 · see citing works

Generation of germline-competent induced pluripotent stem cells

Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,438 · see citing works

The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems

Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,876 · see citing works

Trastuzumab emtansine for HER2-positive advanced breast cancer

Verma, S., Miles, D., Gianni, L., Krop, I. E., Welslau, M., Baselga, J., Pegram, M., Oh, D.-Y., Diéras, V., Guardino, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209124 · Cited by 3,834 · see citing works

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637 · see citing works

COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses

Shereen, M. A., Khan, S., Kazmi, A., Bashir, N., & Siddique, R. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.03.005 · Cited by 3,591 · see citing works

Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives

Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533 · see citing works

Long-Circulating and Target-Specific Nanoparticles: Theory to Practice

Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,521 · see citing works

Transdermal drug delivery

Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,519 · see citing works

The druggable genome

Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305 · see citing works

Car t cell immunotherapy for human cancer

June, C. H., O’Connor, R. S., Kawalekar, O. U., Ghassemi, S., & Milone, M. C. (2018) · Science · doi:10.1126/science.aar6711 · Cited by 3,207 · see citing works

Knocking down barriers: advances in siRNA delivery

Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115 · see citing works

Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release

Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070 · see citing works

Delivery technologies for cancer immunotherapy

Riley, R., June, C. H., Langer, R., & Mitchell, M. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0006-z · Cited by 2,621 · see citing works

Rapid generation of functional human IgG antibodies derived from Fab-on-phage display libraries

Jostock, T., Vanhove, M., Brepoels, E., van Gool, R., Daukandt, M., Wehnert, A., van Hegelsom, R., Dransfield, D., Sexton, D., Devlin, M., et al. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.03.014 · Cited by 2,562 · see citing works

Phage antibodies: filamentous phage displaying antibody variable domains

McCafferty, J., Griffiths, A. D., Winter, G. P., & Chiswell, D. J. (1990) · Nature · doi:10.1038/348552a0 · Cited by 2,427 · see citing works

Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing

Cheng, Q., Wei, T., Farbiak, L., Johnson, L. T., Dilliard, S. A., & Siegwart, D. J. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0669-6 · Cited by 2,383 · see citing works

Toxicity of cationic lipids and cationic polymers in gene delivery

Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286 · see citing works

Strategies and challenges for the next generation of antibody–drug conjugates

Beck, A., Goetsch, L., Dumontet, C., & Corvaïa, N. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.268 · Cited by 2,271 · see citing works

Development of therapeutic antibodies for the treatment of diseases

Lu, R., Hwang, Y., Liu, I.-J., Lee, C., Tsai, H.-Z., Li, H., & Wu, H. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0592-z · Cited by 2,106 · see citing works

Drug Delivery and Targeting

Hillery, A. M., Lloyd, A. W., & Swarbrick, J. (2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,030 · see citing works

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,030 · see citing works

Generation of Functional Human Pancreatic β Cells In Vitro

Pagliuca, F. W., Millman, J. R., Gürtler, M., Segel, M., Van Dervort, A., Ryu, J. H., Peterson, Q. P., Greiner, D., & Melton, D. A. (2014) · Cell · doi:10.1016/j.cell.2014.09.040 · Cited by 2,025 · see citing works

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

Baert, F., Noman, M., Vermeire, S., Assche, G. V., Haens, G. D., Carbonez, A., & Rutgeerts, P. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,012 · see citing works

Drug Solubility: Importance and Enhancement Techniques

Savjani, K. T., Gajjar, A. K., & Savjani, J. (2012) · ISRN Pharmaceutics · doi:10.5402/2012/195727 · Cited by 2,009 · see citing works

The Future of Peptide‐based Drugs

Craik, D. J., Fairlie, D. P., Liras, S. I., & Price, D. A. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12055 · Cited by 1,984 · see citing works

The COVID-19 vaccine development landscape

Le, T. T., Andreadakis, Z., Kumar, A., Román, R. G., Tollefsen, S., Saville, M. K., & Mayhew, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00073-5 · Cited by 1,959 · see citing works

Therapeutic peptides: Historical perspectives, current development trends, and future directions

Lau, J. L., & Dunn, M. K. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.052 · Cited by 1,879 · see citing works

Rational design of cationic lipids for siRNA delivery

Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · see citing works

How were new medicines discovered?

Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812 · see citing works

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Fraietta, J. A., Lacey, S. F., Orlando, E. J., Pruteanu-Malinici, I., Gohil, M., Lundh, S., Boesteanu, A. C., Wang, Y., O’Connor, R. S., Hwang, W.-T., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0010-1 · Cited by 1,785 · see citing works

New Methods of Drug Delivery

Langer, R. (1990) · Science · doi:10.1126/science.2218494 · Cited by 1,778 · see citing works

Nanoparticles in the clinic: an update

Anselmo, A. C., & Mitragotri, S. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10143 · Cited by 1,766 · see citing works

Drug delivery systems: An updated review

Tiwari, G., Tiwari, R., Bannerjee, S., Bhati, L., Pandey, S., Pandey, P., & Sriwastawa, B. (2012) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.96920 · Cited by 1,671 · see citing works

Solid dispersion of poorly water‐soluble drugs: Early promises, subsequent problems, and recent breakthroughs

Serajuddin, A. T. M. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980403l · Cited by 1,652 · see citing works

The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs

Akinc, A., Maier, M. A., Manoharan, M., Fitzgerald, K., Jayaraman, M., Barros, S., Ansell, S., Du, X., Hope, M. J., Madden, T. D., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0591-y · Cited by 1,636 · see citing works

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

Papahadjopoulos, D., Allen, T. M., Gabizón, A., Mayhew, E. G., Matthay, K. K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasiç, D. D., & Redemann, C. T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,621 · see citing works

Chemistry for peptide and protein PEGylation

Roberts, M. J., Bentley, M. D., & Harris, J. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00022-4 · Cited by 1,607 · see citing works

Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy

Di Stasi, A., Tey, S.-K., Dotti, G., Fujita, Y., Kennedy-Nasser, A., Martinez, C., Straathof, K., Liu, E., Durett, A. G., Grilley, B., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106152 · Cited by 1,512 · see citing works

Skin penetration enhancers

Lane, M. E. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.040 · Cited by 1,486 · see citing works

Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs

Yin Win, K., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.050 · Cited by 1,452 · see citing works

Insoluble drug delivery strategies: review of recent advances and business prospects

Kalepu, S., & Nekkanti, V. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.07.003 · Cited by 1,410 · see citing works

Replacing the complementarity-determining regions in a human antibody with those from a mouse

Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., & Winter, G. (1986) · Nature · doi:10.1038/321522a0 · Cited by 1,406 · see citing works

Therapeutic antibodies: successes, limitations and hopes for the future

Chames, P., Van Regenmortel, M., Weiss, E., & Baty, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00190.x · Cited by 1,382 · see citing works

Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.

Abuchowski, A., Es, T. V., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358 · see citing works

Nanoparticles in the clinic

Anselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321 · see citing works

Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade

Wei, S. C., Levine, J. H., Cogdill, A. P., Zhao, Y., Anang, N.-A. A. S., Andrews, M. C., Sharma, P., Wang, J., Wargo, J. A., Pe’er, D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.024 · Cited by 1,302 · see citing works

Defining the Epidemiology of Covid-19 — Studies Needed

Lipsitch, M., Swerdlow, D. L., & Finelli, L. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2002125 · Cited by 1,260 · see citing works

The chemical evolution of oligonucleotide therapies of clinical utility

Khvorova, A., & Watts, J. K. (2017) · Nature Biotechnology · doi:10.1038/nbt.3765 · Cited by 1,216 · see citing works

Particle shape: A new design parameter for micro- and nanoscale drug delivery carriers

Champion, J. A., Katare, Y. K., & Mitragotri, S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.022 · Cited by 1,207 · see citing works

Multivalent <i>N</i> -Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing

Nair, J. K., Willoughby, J. L. S., Chan, A., Charisse, K., Alam, M. R., Wang, Q., Hoekstra, M., Kandasamy, P., Kel’in, A. V., Milstein, S., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505986a · Cited by 1,141 · see citing works

Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs

Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., & Ruoslahti, E. I. (2010) · Science · doi:10.1126/science.1183057 · Cited by 1,080 · see citing works

Development trends for human monoclonal antibody therapeutics

Nelson, A. L., Dhimolea, E., & Reichert, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3229 · Cited by 1,027 · see citing works

Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles

Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 985 · see citing works

Pegylation

Harris, J. M., Martin, N., & Modi, M. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140070-00005 · Cited by 913 · see citing works

CAR T Cell Therapy for Solid Tumors

Newick, K., O'Brien, S., Moon, E., & Albelda, S. M. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-062315-120245 · Cited by 909 · see citing works

Modified mRNA vaccines protect against zika virus infection

Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909 · see citing works

Role of Particle Size in Phagocytosis of Polymeric Microspheres

Champion, J. A., Walker, A. H., & Mitragotri, S. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9562-y · Cited by 887 · see citing works

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.

Nabel, G. J., Nabel, E. G., Yang, Z., Fox, B. A., Plautz, G. E., Gao, X., Huang, L., Shu, S., Gordon, D., & Chang, A. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11307 · Cited by 882 · see citing works

Dendritic-Cell-Based Therapeutic Cancer Vaccines

Palucka, K., & Banchereau, J. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.004 · Cited by 869 · see citing works

Receptor-mediated in vitro gene transformation by a soluble DNA carrier system.

Wu, G. Y., & Wu, C. H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61209-8 · Cited by 855 · see citing works

Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery

Yu, J., Zhang, Y., Ye, Y., DiSanto, R., Sun, W., Ranson, D., Ligler, F. S., Buse, J. B., & Gu, Z. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505405112 · Cited by 852 · see citing works

Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance

Smith, M. R. (2003) · Oncogene · doi:10.1038/sj.onc.1206939 · Cited by 835 · see citing works

Pharmacokinetics of Monoclonal Antibodies

Ryman, J. T., & Meibohm, B. (2017) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12224 · Cited by 815 · see citing works

In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers

Smith, T. T., Stephan, S. B., Moffett, H. F., McKnight, L. E., Ji, W., Reiman, D., Bonagofski, E., Wohlfahrt, M. E., Pillai, S. P. S., & Stephan, M. T. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.57 · Cited by 788 · see citing works

Antisense oligonucleotides: the next frontier for treatment of neurological disorders

Rinaldi, C., & Wood, M. J. A. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.148 · Cited by 788 · see citing works

PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine

Cheever, M. A., & Higano, C. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3126 · Cited by 780 · see citing works

Antibody-Drug Conjugates in Cancer Therapy

Sievers, E. L., & Senter, P. D. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-050311-201823 · Cited by 772 · see citing works

Global Manufacturing of CAR T Cell Therapy

Levine, B. L., Miskin, J., Wonnacott, K., & Keir, C. (2017) · Molecular Therapy - Methods &amp; Clinical Development · doi:10.1016/j.omtm.2016.12.006 · Cited by 765 · see citing works

Basics and Recent Advances in Peptide and Protein Drug Delivery

Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 760 · see citing works

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles

Stephan, M. T., Moon, J. J., Um, S. H., Bershteyn, A., & Irvine, D. J. (2010) · Nature Medicine · doi:10.1038/nm.2198 · Cited by 752 · see citing works

Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee

Bartlett, W., Skinner, J. A., Gooding, C. R., Carrington, R., Flanagan, A. M., Briggs, T. W. R., & Bentley, G. (2005) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.87b5.15905 · Cited by 737 · see citing works

Expression of therapeutic proteins after delivery of chemically modified mRNA in mice

Kormann, M. S. D., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., Schams, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1733 · Cited by 733 · see citing works

PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs

Turecek, P. L., Bossard, M. J., Schoetens, F., & Ivens, I. A. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.015 · Cited by 733 · see citing works

Controlled drug delivery systems: Past forward and future back

Park, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.054 · Cited by 721 · see citing works

Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties

Larsen, C. P., Pearson, T. C., Adams, A. B., Tso, P. L., Shirasugi, N., Strobertb, E., Anderson, D., Cowan, S. R., Price, K., Naemura, J. R., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00749.x · Cited by 721 · see citing works

GalNAc-siRNA conjugates: leading the way for delivery of RNAi therapeutics

Springer, A. D., & Dowdy, S. F. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0736 · Cited by 711 · see citing works

Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-competent mice

Vegas, A. J., Veiseh, O., Gürtler, M., Millman, J. R., Pagliuca, F. W., Bader, A. R., Doloff, J. C., Li, J., Chen, M., Olejnik, K., et al. (2016) · Nature Medicine · doi:10.1038/nm.4030 · Cited by 710 · see citing works

Cytokines in Cancer Immunotherapy

Lee, S. Y., & Margolin, K. A. (2011) · Cancers · doi:10.3390/cancers3043856 · Cited by 695 · see citing works

Cancer nanomedicine: from targeted delivery to combination therapy

Xu, X., Ho, W., Zhang, X., Bertrand, N., & Farokhzad, O. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.01.001 · Cited by 693 · see citing works

Phosphorothioates, Essential Components of Therapeutic Oligonucleotides

Eckstein, F. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2014.0506 · Cited by 684 · see citing works

PEGylation of therapeutic proteins

Jevševar, S., Kunstelj, M., & Porekar, V. G. (2010) · Biotechnology Journal · doi:10.1002/biot.200900218 · Cited by 681 · see citing works

Non-invasive delivery strategies for biologics

Anselmo, A. C., Gokarn, Y. R., & Mitragotri, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.183 · Cited by 671 · see citing works

Strategic Approaches to Optimizing Peptide ADME Properties

Di, L. (2015) · The AAPS Journal · doi:10.1208/s12248-014-9687-3 · Cited by 669 · see citing works

Advances in oral peptide therapeutics

Drucker, D. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0053-0 · Cited by 665 · see citing works

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

Tang, L., Zheng, Y., Melo, M. B., Mabardi, L., Castaño, A. P., Xie, Y., Li, N., Kudchodkar, S. B., Wong, H. C., Jeng, E. K., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4181 · Cited by 663 · see citing works

Advances in the delivery of RNA therapeutics: from concept to clinical reality

Kaczmarek, J. C., Kowalski, P. S., & Anderson, D. G. (2017) · Genome Medicine · doi:10.1186/s13073-017-0450-0 · Cited by 656 · see citing works

Antibody–drug conjugates: targeted drug delivery for cancer

Alley, S. C., Okeley, N. M., & Senter, P. D. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.170 · Cited by 653 · see citing works

COVID-19 vaccine development and a potential nanomaterial path forward

Shin, M. D., Shukla, S., Chung, Y. H., Beiss, V., Chan, S. K., Ortega-Rivera, O. A., Wirth, D. M., Chen, A., Sack, M., Pokorski, J. K., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0737-y · Cited by 652 · see citing works

Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects

Kubitza, D., Becka, M., Wensing, G., Voith, B., & Zuehlsdorf, M. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0043-5 · Cited by 639 · see citing works

Mechanism of oligonucleotide release from cationic liposomes.

Zelphati, O., & Szoka, F. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11493 · Cited by 634 · see citing works

Improving cancer immunotherapy through nanotechnology

Goldberg, M. S. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0186-9 · Cited by 628 · see citing works

Cationic liposome-mediated gene transfer.

Gao, X., & Huang, L. (1995) · PubMed · Cited by 620 · see citing works

A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE® Bone Graft)

McKay, W. F., Peckham, S. M., & Badura, J. M. (2007) · International Orthopaedics · doi:10.1007/s00264-007-0418-6 · Cited by 617 · see citing works

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

Lotze, M. T., Matory, Y. L., Ettinghausen, S. E., Rayner, A. A., Sharrow, S. O., Seipp, C. A., Custer, M. C., & Rosenberg, S. A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.4.2865 · Cited by 613 · see citing works

Driving CAR T-cells forward

Jackson, H. J., Rafiq, S., & Brentjens, R. J. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.36 · Cited by 613 · see citing works

On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids

Hafez, I., Maurer, N., & Cullis, P. R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301506 · Cited by 601 · see citing works

Anti‐ <scp>PEG</scp> immunity: emergence, characteristics, and unaddressed questions

Yang, Q., & Lai, S. K. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1339 · Cited by 593 · see citing works

PEGylated antibodies and antibody fragments for improved therapy: a review

Chapman, A. P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00026-1 · Cited by 558 · see citing works

Novel Drug Delivery Systems

Chien, Y. W. (1991) · CRC Press eBooks · doi:10.1201/9780367805456 · Cited by 558 · see citing works

Evolution of the COVID-19 vaccine development landscape

Le, T. T., Cramer, J. P., Chen, R. H., & Mayhew, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00151-8 · Cited by 556 · see citing works

Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates

Vegas, A. J., Veiseh, O., Doloff, J. C., Ma, M., Tam, H. H., Bratlie, K., Li, J., Bader, A. R., Langan, E., Olejnik, K., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3462 · Cited by 551 · see citing works

Beyond natural antibodies: the power of in vitro display technologies

Bradbury, A. M., Sidhu, S. S., Dübel, S., & McCafferty, J. (2011) · Nature Biotechnology · doi:10.1038/nbt.1791 · Cited by 548 · see citing works

Nucleic-acid therapeutics: basic principles and recent applications

Opalinska, J., & Gewirtz, A. M. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd837 · Cited by 535 · see citing works

Delivery of Therapeutic Proteins

Pisal, D. S., Kosloski, M. P., & Balu-Iyer, S. V. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22054 · Cited by 532 · see citing works

Materials for oral delivery of proteins and peptides

Brown, T. D., Whitehead, K. A., & Mitragotri, S. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0156-6 · Cited by 527 · see citing works

Developing a new class of engineered live bacterial therapeutics to treat human diseases

Charbonneau, M. R., Isabella, V. M., Li, N., & Kurtz, C. B. (2020) · Nature Communications · doi:10.1038/s41467-020-15508-1 · Cited by 523 · see citing works

Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies

Shih, T., & Lindley, C. M. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.11.015 · Cited by 521 · see citing works

Chimeric antigen receptor T-cell therapies for lymphoma

Brudno, J. N., & Kochenderfer, J. N. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.128 · Cited by 518 · see citing works

The SARS-CoV-2 Vaccine Pipeline: an Overview

Chen, W., Strych, U., Hotez, P. J., & Bottazzi, M. E. (2020) · Current Tropical Medicine Reports · doi:10.1007/s40475-020-00201-6 · Cited by 512 · see citing works

How sugars protect proteins in the solid state and during drying (review): Mechanisms of stabilization in relation to stress conditions

Mensink, M. A., Frijlink, H. W., Maarschalk, K. V. D. V., & Hinrichs, W. L. J. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.01.024 · Cited by 502 · see citing works

Cell-penetrating peptides: tools for intracellular delivery of therapeutics

Deshayes, S., Morris, M. C., Divita, G., & Heitz, F. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5109-0 · Cited by 483 · see citing works

Mesenchymal Stem Cell: Keystone of the Hematopoietic Stem Cell Niche and a Stepping-Stone for Regenerative Medicine

Frenette, P. S., Pinho, S., Lucas, D., & Scheiermann, C. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095919 · Cited by 462 · see citing works

Improving protein therapeutics with sustained-release formulations

Putney, S. D., & Burke, P. A. (1998) · Nature Biotechnology · doi:10.1038/nbt0298-153 · Cited by 461 · see citing works

Engineering bacteria for diagnostic and therapeutic applications

Riglar, D. T., & Silver, P. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.172 · Cited by 460 · see citing works

Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.

Gabrilovich, D. I., Ishida, T., Nadaf, S., Ohm, J. E., & Carbone, D. P. (1999) · PubMed · Cited by 459 · see citing works

Chemical Modification of siRNAs for In Vivo Use

Behlke, M. A. (2008) · Oligonucleotides · doi:10.1089/oli.2008.0164 · Cited by 456 · see citing works

Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures

Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00343-6 · Cited by 454 · see citing works

mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials

Feldman, R. A., Fuhr, R., Smolenov, I., (Mick) Ribeiro, A., Panther, L., Watson, M., Senn, J. J., Smith, M., Almarsson, Ӧ., Pujar, H. S., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.074 · Cited by 454 · see citing works

CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia

Xu, L., Wang, J., Liu, Y., Xie, L., Su, B., Mou, D., Wang, L., Liu, T., Wang, X., Zhang, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1817426 · Cited by 454 · see citing works

Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin

Jonassen, I., Havelund, S., Hoeg-Jensen, T., Steensgaard, D. B., Wahlund, P.-O., & Ribel, U. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0739-z · Cited by 448 · see citing works

Biopolymer implants enhance the efficacy of adoptive T-cell therapy

Stephan, S. B., Taber, A. M., Jileaeva, I., Pegues, E. P., Sentman, C. L., & Stephan, M. T. (2014) · Nature Biotechnology · doi:10.1038/nbt.3104 · Cited by 440 · see citing works

Givosiran: First Approval

Scott, L. J. (2020) · Drugs · doi:10.1007/s40265-020-01269-0 · Cited by 422 · see citing works

Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes

Wang, X., Ishida, T., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.010 · Cited by 421 · see citing works

Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap

Song, W., Shen, L., Wang, Y., Liu, Q., Goodwin, T. J., Li, J., Dorosheva, O., Liu, T., Liu, R., & Huang, L. (2018) · Nature Communications · doi:10.1038/s41467-018-04605-x · Cited by 408 · see citing works

Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems

Villa, C. H., Anselmo, A. C., Mitragotri, S., & Muzykantov, V. R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.007 · Cited by 398 · see citing works

Programming a Human Commensal Bacterium, Bacteroides thetaiotaomicron, to Sense and Respond to Stimuli in the Murine Gut Microbiota

Mimee, M., Tucker, A. C., Voigt, C. A., & Lu, T. K. (2015) · Cell Systems · doi:10.1016/j.cels.2015.06.001 · Cited by 387 · see citing works

Immunogenicity of protein therapeutics: The key causes, consequences and challenges

Baker, M., Reynolds, H. M., Lumicisi, B., & Bryson, C. J. (2010) · Self/Nonself · doi:10.4161/self.1.4.13904 · Cited by 372 · see citing works

Design of Ester Prodrugs to Enhance Oral Absorption of Poorly Permeable Compounds: Challenges to the Discovery Scientist

Beaumont, K. C., Webster, R., Gardner, I. B., & Dack, K. N. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489253 · Cited by 369 · see citing works

Marketed therapeutic antibodies compendium

Reichert, J. M. (2012) · mAbs · doi:10.4161/mabs.19931 · Cited by 368 · see citing works

Origin and evolution of high throughput screening

Pereira, D. A., & Williams, J. A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707373 · Cited by 367 · see citing works

Alginate encapsulation as long-term immune protection of allogeneic pancreatic islet cells transplanted into the omental bursa of macaques

Bochenek, M. A., Veiseh, O., Vegas, A. J., McGarrigle, J. J., Qi, M., Marchese, E., Omami, M., Doloff, J. C., Mendoza-Elias, J., Nourmohammadzadeh, M., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0275-1 · Cited by 367 · see citing works

Delivering Nanoparticles to Lungs while Avoiding Liver and Spleen through Adsorption on Red Blood Cells

Anselmo, A. C., Gupta, V., Zern, B. J., Pan, D. C., Zakrewsky, M., Muzykantov, V. R., & Mitragotri, S. (2013) · ACS Nano · doi:10.1021/nn404853z · Cited by 366 · see citing works

Cellular backpacks for macrophage immunotherapy

Shields, C. W., Evans, M. A., Wang, L. L.-W., Baugh, N., Iyer, S., Wu, D., Zhao, Z.-M., Pusuluri, A., Ukidve, A., Pan, D. C., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz6579 · Cited by 360 · see citing works

GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade

Gargett, T., Yu, W., Dotti, G., Yvon, E. S., Christo, S. N., Hayball, J. D., Lewis, I. D., Brenner, M. K., & Brown, M. P. (2016) · Molecular Therapy · doi:10.1038/mt.2016.63 · Cited by 356 · see citing works

Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects

Sharma, P. C., Jain, A., Jain, S., Pahwa, R., & Yar, M. S. (2010) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756360903373350 · Cited by 354 · see citing works

Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes

Friend, D. S., Papahadjopoulos, D., & Debs, R. J. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00219-7 · Cited by 352 · see citing works

Oral insulin delivery1Abbreviations: GI, gastrointestinal; IDDM, insulin-dependent diabetes mellitus; IU, international units; NIDDM, non-insulin-dependent diabetes mellitus; PIN, phase inversion nanoencapsulation; ZOT, zona occludens toxin.1

Carino, G. P., & Mathiowitz, E. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00075-1 · Cited by 347 · see citing works

Immune-mediated approaches against COVID-19

Florindo, H. F., Kleiner, R., Vaskovich‐Koubi, D., Acúrcio, R. C., Carreira, B., Yeini, E., Tiram, G., Liubomirski, Y., & Satchi‐Fainaro, R. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0732-3 · Cited by 342 · see citing works

Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain

Chey, W. D., Webster, L. R., Sostek, M. B., Lappalainen, J., Barker, P. N., & Tack, J. F. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310246 · Cited by 328 · see citing works

Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration

Frost, G. I. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.4.427 · Cited by 323 · see citing works

Poly(2‐ethyl‐2‐oxazoline) as Alternative for the Stealth Polymer Poly(ethylene glycol): Comparison of in vitro Cytotoxicity and Hemocompatibility

Bauer, M., Lautenschläger, C., Kempe, K., Tauhardt, L., Schubert, U. S., & Fischer, D. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201200017 · Cited by 322 · see citing works

The First Approved Gene Therapy Product for Cancer Ad- p53 (Gendicine): 12 Years in the Clinic

Zhang, W., Li, L., Li, D., Liu, J., Li, X., Li, W., Xu, X., Zhang, M. J., Chandler, L. A., Lin, H., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.218 · Cited by 320 · see citing works

High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria

Hamilton, M. J., Weingarden, A. R., Unno, T., Khoruts, A., & Sadowsky, M. J. (2013) · Gut Microbes · doi:10.4161/gmic.23571 · Cited by 315 · see citing works

A natural history of botanical therapeutics

Schmidt, B. M., Ribnicky, D., Poulev, A., Logendra, S., Cefalu, W. T., & Raskin, I. (2008) · Metabolism · doi:10.1016/j.metabol.2008.03.001 · Cited by 310 · see citing works

Cell-mediated delivery of nanoparticles: Taking advantage of circulatory cells to target nanoparticles

Anselmo, A. C., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.050 · Cited by 310 · see citing works

Synthetic materials at the forefront of gene delivery

Lostalé‐Seijo, I., & Montenegro, J. (2018) · Nature Reviews Chemistry · doi:10.1038/s41570-018-0039-1 · Cited by 310 · see citing works

Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

Shum, T., Omer, B. A., Tashiro, H., Kruse, R. L., Wagner, D. L., Parikh, K., Yi, Z., Sauer, T., Liu, D., Parihar, R., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0538 · Cited by 297 · see citing works

The rise and rise of drug delivery

Rosen, H., & Abribat, T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1721 · Cited by 296 · see citing works

Antibody–Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic Index

Coats, S. R., Williams, M. B., Kebble, B., Dixit, R., Tseng, L., Yao, N., Tice, D. A., & Soria, J. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0272 · Cited by 290 · see citing works

Quality cell therapy manufacturing by design

Lipsitz, Y. Y., Timmins, N. E., & Zandstra, P. (2016) · Nature Biotechnology · doi:10.1038/nbt.3525 · Cited by 287 · see citing works

The Druggable Genome: Evaluation of Drug Targets in Clinical Trials Suggests Major Shifts in Molecular Class and Indication

Rask-Andersen, M., Masuram, S., & Schiöth, H. B. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135943 · Cited by 282 · see citing works

Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study

Dlugi, A. M., Miller, J. D., & Knittle, J. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53755-8 · Cited by 279 · see citing works

T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation

Jawa, V., Cousens, L. P., Awwad, M., Wakshull, E., Kropshofer, H., & Groot, A. S. D. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.09.006 · Cited by 271 · see citing works

The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal And Antiviral Drugs

Kucers, A. (1997) · Cited by 269 · see citing works

Enhancing cell therapies from the outside in: Cell surface engineering using synthetic nanomaterials

Stephan, M. T., & Irvine, D. J. (2011) · Nano Today · doi:10.1016/j.nantod.2011.04.001 · Cited by 267 · see citing works

Solvent Effects on the Preferred Conformation of Poly(ethylene glycols)

Liu, K.-J., & Parsons, J. L. (1969) · Macromolecules · doi:10.1021/ma60011a015 · Cited by 262 · see citing works

Kinetics of distribution of substances administered to the body, II : The intravascular modes of administration

Teorell, T. (1937) · Archives internationales de pharmacodynamie et de thérapie · Cited by 260 · see citing works

Interleukin-23 engineering improves CAR T cell function in solid tumors

Ma, X., Shou, P., Smith, C. C., Chen, Y., Du, H., Sun, C., Kren, N. P., Michaud, D. E., Ahn, S., Vincent, B. G., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0398-2 · Cited by 253 · see citing works

Galactose and N-acetylgalactosamine-specific endocytosis of glycopeptides by isolated rat hepatocytes

Baenziger, J., & Fiete, D. (1980) · Cell · doi:10.1016/0092-8674(80)90371-2 · Cited by 248 · see citing works

Nanotechnology intervention of the microbiome for cancer therapy

Song, W., Anselmo, A. C., & Huang, L. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0589-5 · Cited by 247 · see citing works

Safety and immunologic effects of IL-15 administration in nonhuman primates

Berger, C., Berger, M., Hackman, R. C., Gough, M., Elliott, C., Jensen, M. C., & Riddell, S. R. (2009) · Blood · doi:10.1182/blood-2008-12-189266 · Cited by 244 · see citing works

Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape

Endoh, T., & Ohtsuki, T. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.005 · Cited by 242 · see citing works

Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy

Corey, D. R. (2017) · Nature Neuroscience · doi:10.1038/nn.4508 · Cited by 242 · see citing works

Enteric coated HPMC capsules designed to achieve intestinal targeting

Cole, E. T., Scott, R. A., Connor, A. L., Wilding, I. R., Petereit, H.-U., Schminke, C., Beckert, T. E., & Cadé, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00871-7 · Cited by 241 · see citing works

Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS

Dou, H., Grotepas, C. B., McMillan, J., Destache, C. J., Chaubal, M. V., Werling, J. O., Kipp, J., Rabinow, B. E., & Gendelman, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900274 · Cited by 238 · see citing works

Armored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy

Yeku, O., & Brentjens, R. J. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150291 · Cited by 238 · see citing works

Anti-VEGF therapies in the clinic

Meadows, K. L., & Hurwitz, H. I. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006577 · Cited by 237 · see citing works

Conformation of poly(ethylene oxide) in the solid state, melt and solution measured by Raman scattering

Maxfield, J., & Shepherd, I. W. (1975) · Polymer · doi:10.1016/0032-3861(75)90008-7 · Cited by 236 · see citing works

Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas

Kauer, T. M., de Figueiredo, J. L., Hingtgen, S., & Shah, K. (2011) · Nature Neuroscience · doi:10.1038/nn.3019 · Cited by 234 · see citing works

Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications

Benizri, S., Gissot, A., Martin, A., Vialet, B., Grinstaff, M. W., & Barthélémy, P. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00761 · Cited by 233 · see citing works

Current drug research on PEGylation with small molecular agents

Li, W., Zhan, P., Clercq, E. D., Lou, H., & Liu, X. (2012) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2012.07.006 · Cited by 232 · see citing works

Tisagenlecleucel — the first approved CAR-T-cell therapy: implications for payers and policy makers

Prasad, V. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.156 · Cited by 229 · see citing works

Clinical trials of Herceptin® (trastuzumab)

Baselga, J. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00404-4 · Cited by 227 · see citing works

Microneedle patches for vaccination in developing countries

Arya, J. M., & Prausnitz, M. R. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.019 · Cited by 224 · see citing works

Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases

Volkman, R., & Offen, D. (2017) · Stem Cells · doi:10.1002/stem.2651 · Cited by 222 · see citing works

Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells

Eggermont, L. J., Paulis, L. E. M., Tel, J., & Figdor, C. G. (2014) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.06.007 · Cited by 218 · see citing works

Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses

Chien, S., Rogge, M. C., Gisclon, L. G., Curtin, C. R., Wong, F., Natarajan, J., Williams, R. R., Fowler, C. L., Cheung, W. K., & Chow, A. T. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2256 · Cited by 216 · see citing works

The history and development of the fentanyl series

Stanley, T. H. (1992) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(92)90047-l · Cited by 214 · see citing works

Fecal microbiota transplantation in relapsing Clostridium difficile infection

Rohlke, F., & Stollman, N. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12453637 · Cited by 214 · see citing works

Cell-Permeable Cyclic Peptides from Synthetic Libraries Inspired by Natural Products

Hewitt, W. M., Leung, S. S. F., Pye, C. R., Ponkey, A. R., Bednarek, M. A., Jacobson, M. P., & Lokey, R. S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508766b · Cited by 214 · see citing works

High-throughput nuclear delivery and rapid expression of DNA via mechanical and electrical cell-membrane disruption

Ding, X., Stewart, M. P., Sharei, A., Weaver, J. C., Langer, R., & Jensen, K. F. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0039 · Cited by 213 · see citing works

Injectable controlled release depots for large molecules

Schwendeman, S. P., Shah, R. B., Bailey, B. A., & Schwendeman, A. S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.057 · Cited by 209 · see citing works

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

Devaud, C., John, L. B., Westwood, J. A., Darcy, P. K., & Kershaw, M. H. (2013) · OncoImmunology · doi:10.4161/onci.25961 · Cited by 207 · see citing works

Discovery of Ritonavir, a Potent Inhibitor of HIV Protease with High Oral Bioavailability and Clinical Efficacy

Kempf, D. J., Sham, H. L., Marsh, K. C., Flentge, C. A., Betebenner, D. A., Green, B. E., McDonald, E. J., Vasavanonda, S., Saldivar, A. C., Wideburg, N. E., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970636+ · Cited by 205 · see citing works

How mRNA therapeutics are entering the monoclonal antibody field

Van Hoecke, L., & Roose, K. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1804-8 · Cited by 205 · see citing works

Physiological Pharmaceutics: Barriers to Drug Absorption

WILSON, C. G., Washington, N., & Washington, C. (2000) · Cited by 202 · see citing works

A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection

Kose, N., Fox, J. M., Sapparapu, G., Bombardi, R., Tennekoon, R. N., de Silva, A. D., Elbashir, S. M., Theisen, M. A., Humphris-Narayanan, E., Ciaramella, G., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw6647 · Cited by 202 · see citing works

Immunogenicity of anti-tumor necrosis factor antibodies-toward improved methods of anti-antibody measurement.

Aarden, L., Ruuls, S., & Wolbink, G. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.06.011 · Cited by 198 · see citing works

Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer

Povsic, T. J., Lawrence, M. G., Lincoff, A. M., Mehran, R., Rusconi, C. P., Zelenkofske, S. L., Huang, Z., Sailstad, J. M., Armstrong, P. W., Steg, P. G., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.04.058 · Cited by 198 · see citing works

Immunogenicity and autoimmunity during anti-TNF therapy

Atzeni, F., Talotta, R., Salaffi, F., Cassinotti, A., Varisco, V., Battellino, M., Ardizzone, S., Pace, F., & Sarzi‐Puttini, P. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.10.021 · Cited by 196 · see citing works

Drug delivery systems for RNA therapeutics

Paunovska, K., Loughrey, D., & Dahlman, J. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00439-4 · Cited by 1,349 · see citing works

Polymeric Nanoparticles for Drug Delivery

Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,229 · see citing works

Smart nanoparticles for cancer therapy

Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works

Advances in drug delivery systems, challenges and future directions

Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., Okoroafor, C. C., Eze, S. C., Kalu, O. L., Odoh, E. C., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17488 · Cited by 1,023 · see citing works

Recent advances in transdermal drug delivery systems: a review

Jeong, W. Y., Kwon, M., Choi, H. E., & Kim, K. S. (2021) · Biomaterials Research · doi:10.1186/s40824-021-00226-6 · Cited by 598 · see citing works

Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems

Baryakova, T. H., Pogostin, B. H., Langer, R., & McHugh, K. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00670-0 · Cited by 499 · see citing works

Evolution of drug delivery systems: From 1950 to 2020 and beyond

Park, H., Otte, A., & Park, K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.030 · Cited by 478 · see citing works

Scale-up polymeric-based nanoparticles drug delivery systems: Development and challenges

Herdiana, Y., Wathoni, N., Shamsuddin, S., & Muchtaridi, M. (2022) · OpenNano · doi:10.1016/j.onano.2022.100048 · Cited by 335 · see citing works

Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics.

Wei, D.-S., Sun, Y., Zhu, H., & Fu, Q.-R. (2023) · ACS Nano · doi:10.1021/acsnano.3c06019 · Cited by 276 · see citing works

Metal–phenolic network composites: from fundamentals to applications

Lin, Z., Liu, H., Richardson, J. J., Xu, W., Chen, J., Zhou, J., & Caruso, F. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00273j · Cited by 299 · see citing works

Biosafety of mesoporous silica nanoparticles; towards clinical translation

Lérida‐Viso, A., Estepa‐Fernández, A., García‐Fernández, A., Martí‐Centelles, V., & Martínez‐Máñez, R. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115049 · Cited by 289 · see citing works

Magneto‐Responsive Microneedle Robots for Intestinal Macromolecule Delivery

Zhang, X., Chen, G., Fu, X., Wang, Y., & Zhao, Y. (2021) · Advanced Materials · doi:10.1002/adma.202104932 · Cited by 265 · see citing works

Metal–organic frameworks for biological applications

Lázaro, I. A., Chen, X., Ding, M., Eskandari, A., Fairen‐Jiménez, D., Giménez‐Marqués, M., Gref, R., Lin, W., Luo, T., & Forgan, R. S. (2024) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00320-8 · Cited by 274 · see citing works

Recent Applications of PLGA in Drug Delivery Systems

Yang, J., Zeng, H., Luo, Y., Chen, Y., Wang, M., Wu, C., & Hu, P. (2024) · Polymers · doi:10.3390/polym16182606 · Cited by 268 · see citing works

Sustainability in peptide chemistry: current synthesis and purification technologies and future challenges

Ferrazzano, L., Catani, M., Cavazzini, A., Martelli, G., Corbisiero, D., Cantelmi, P., Fantoni, T., Mattellone, A., Luca, C. D., Felletti, S., et al. (2022) · Green Chemistry · doi:10.1039/d1gc04387k · Cited by 251 · see citing works

Degradable Polymeric Bio(nano)materials and Their Biomedical Applications: A Comprehensive Overview and Recent Updates

Kuperkar, K. C., Atanase, L. I., Bahadur, A., Crivei, I. C., & Bahadur, P. (2024) · Polymers · doi:10.3390/polym16020206 · Cited by 244 · see citing works

Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release

Liu, J., Cabral, H., & Mi, P. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115239 · Cited by 239 · see citing works

Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles

Nguyen, P. H. D., Jayasinghe, M. K., Le, A. H., Peng, B., & Le, M. T. N. (2023) · ACS Nano · doi:10.1021/acsnano.2c11965 · Cited by 233 · see citing works

Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities

Claridge, B., Lozano, J., Poh, Q. H., & Greening, D. W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.734720 · Cited by 235 · see citing works

Phytosomes as an Emerging Nanotechnology Platform for the Topical Delivery of Bioactive Phytochemicals

Alharbi, W. S., Almughem, F. A., Almehmady, A. M., Jarallah, S. J., Alsharif, W. K., Alzahrani, N. M., & Alshehri, A. A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091475 · Cited by 204 · see citing works

Tumor Abnormality-Oriented Nanomedicine Design

Zhou, Q., Xiang, J., Qiu, N., Wang, Y., Piao, Y., Shao, S., Tang, J., Zhou, Z., & Shen, Y. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00062 · Cited by 194 · see citing works

Biomedical polymers: synthesis, properties, and applications

Chen, W., Chen, Q., Chen, Q., Cui, C., Duan, S., Kang, Y., Liu, Y., Liu, Y., Muhammad, W., Shao, S., et al. (2022) · Science China Chemistry · doi:10.1007/s11426-022-1243-5 · Cited by 191 · see citing works

Photon-Controlled Pyroptosis Activation (PhotoPyro): An Emerging Trigger for Antitumor Immune Response

Li, M., Kim, J., Rha, H., Son, S., Levine, M. S., Xu, Y., Sessler, J. L., & Kim, J. S. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c01231 · Cited by 182 · see citing works

Harnessing artificial intelligence for the next generation of 3D printed medicines

Elbadawi, M., McCoubrey, L. E., Gavins, F. K. H., Ong, J. J., Goyanes, Á., Gaisford, S., & Basit, A. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.015 · Cited by 178 · see citing works

Biomaterials coating for on-demand bacteria delivery: Selective release, adhesion, and detachment

Liu, J., Li, W., Wang, Y., Ding, Y., Lee, A., & Hu, Q. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101291 · Cited by 171 · see citing works

Let’s talk about sex: Differences in drug therapy in males and females

Madla, C. M., Gavins, F. K. H., Merchant, H. A., Orlu, M., Murdan, S., & Basit, A. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.014 · Cited by 167 · see citing works

Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry

Yi, W., Xiao, P., Liu, X., Zhao, Z., Sun, X., Wang, J., Zhou, L., Wang, G., Cao, H., Wang, D., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01250-1 · Cited by 173 · see citing works

Perspectives on recent advancements in energy harvesting, sensing and bio-medical applications of piezoelectric gels

Vijayakanth, T., Shankar, S., Finkelstein‐Zuta, G., Rencus‐Lazar, S., Gilead, S., & Gazit, E. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00202k · Cited by 161 · see citing works

Bioorthogonal chemistry for prodrug activation in vivo

Fu, Q., Shen, S., Sun, P., 谷, 知., Bai, Y., Wang, X., & Liu, Z. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00889k · Cited by 158 · see citing works

Tumor–Antigen Activated Dendritic Cell Membrane-Coated Biomimetic Nanoparticles with Orchestrating Immune Responses Promote Therapeutic Efficacy against Glioma

Ma, X., Kuang, L., Yin, Y., Tang, L., Zhang, Y., Fan, Q., Wang, F., Dong, Z., Wang, W., Yin, T., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c09033 · Cited by 154 · see citing works

Bio-Inspired Nanomaterials for Micro/Nanodevices: A New Era in Biomedical Applications

Harun‐Ur‐Rashid, M., Jahan, I., Foyez, T., & Imran, A. B. (2023) · Micromachines · doi:10.3390/mi14091786 · Cited by 159 · see citing works

CARBON DOTS: Bioimaging and Anticancer Drug Delivery

Bartkowski, M., Zhou, Y., Mustafa, M. N. A., Eustace, A. J., & Giordani, S. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202303982 · Cited by 145 · see citing works

Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment

Coghi, P. S., Li, J., Hosmane, N. S., & Zhu, Y. (2023) · Medicinal Research Reviews · doi:10.1002/med.21964 · Cited by 142 · see citing works

Stimulus-responsive self-assembled prodrugs in cancer therapy

Dong, X., Brahma, R. K., Fang, C., & Yao, S. Q. (2022) · Chemical Science · doi:10.1039/d2sc01003h · Cited by 141 · see citing works

Synthetic Polymers for Drug, Gene, and Vaccine Delivery

Xu, Y., Chen, J., Ding, J., Sun, J., Song, W., Tang, Z., Xiao, C., & Chen, X. (2025) · Polymer science & technology. · doi:10.1021/polymscitech.5c00010 · Cited by 139 · see citing works

Semiconducting Polymer Nanoparticles with Surface‐Mimicking Protein Secondary Structure as Lysosome‐Targeting Chimaeras for Self‐Synergistic Cancer Immunotherapy

Qi, J., Jia, S., Kang, X., Wu, X., Hong, Y., Shan, K., Kong, X., Wang, Z., & Ding, D. (2022) · Advanced Materials · doi:10.1002/adma.202203309 · Cited by 135 · see citing works

Aptamer-Based Targeted Delivery of Functional Nucleic Acids

Xie, S., Sun, W., Fu, T., Liu, X., Chen, P., Qiu, L., Qu, F., & Tan, W. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c00841 · Cited by 130 · see citing works

Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches

Kansız, S., & Elçin, Y. M. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.102930 · Cited by 131 · see citing works

Drug Delivery Systems in Regenerative Medicine: An Updated Review

Mansour, A., Romani, M., Acharya, A. B., Rahman, B., Verron, É., & Badran, Z. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020695 · Cited by 134 · see citing works

Electrospun nanofibers for drug delivery applications: Methods and mechanism

Abdulhameed, M. M., Khan, S. A. P. M., Thamer, B. M., Nirmala, R., El‐Hamshary, H., & El-Newehy, M. H. (2022) · Polymers for Advanced Technologies · doi:10.1002/pat.5884 · Cited by 125 · see citing works

Roll-to-roll, high-resolution 3D printing of shape-specific particles

Kronenfeld, J. M., Rother, L., Saccone, M. A., Dulay, M. T., & DeSimone, J. M. (2024) · Nature · doi:10.1038/s41586-024-07061-4 · Cited by 123 · see citing works

Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics

Barman, P., Joshi, S., Sharma, S., Preet, S., Sharma, S., & Saini, A. (2023) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-023-10524-3 · Cited by 122 · see citing works

Novel Drug Delivery Systems: An Important Direction for Drug Innovation Research and Development

Chen, Q., Yang, Z., Liu, H., Man, J., Oladejo, A. O., Ibrahim, S., Wang, S., & Hao, B. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050674 · Cited by 130 · see citing works

Recent Advances in Pro-PROTAC Development to Address On-Target Off-Tumor Toxicity

Chen, C., Yang, Y., Wang, Z., Li, H., Dong, C., & Zhang, X. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00302 · Cited by 117 · see citing works

A Comprehensive Review of Stimuli-Responsive Smart Polymer Materials—Recent Advances and Future Perspectives

Balcerak, A., Dzwonkowska-Zarzycka, M., & Kabatc, J. (2024) · Materials · doi:10.3390/ma17174255 · Cited by 118 · see citing works

A critical assessment of technical advances in pharmaceutical removal from wastewater – A critical review

Kumar, V., Lakkaboyana, S. K., Sharma, N., Chakraborty, P., Umesh, M., Pasrija, R., Thomas, J. B., Kalebar, V. U., Iyyappan, J., Awasthi, M. K., et al. (2023) · Case Studies in Chemical and Environmental Engineering · doi:10.1016/j.cscee.2023.100363 · Cited by 116 · see citing works

Discovery and delivery strategies for engineered live biotherapeutic products

Heavey, M. K., Durmusoglu, D., Crook, N., & Anselmo, A. C. (2021) · Trends in biotechnology · doi:10.1016/j.tibtech.2021.08.002 · Cited by 113 · see citing works

Artificial Intelligence‐Driven Nanoarchitectonics for Smart Targeted Drug Delivery

Bae, H., Ji, H., Konstantinov, K., Sluyter, R., Ariga, K., Kim, J. H., & Kim, J. H. (2025) · Advanced Materials · doi:10.1002/adma.202510239 · Cited by 121 · see citing works

Triplet–triplet annihilation photon upconversion-mediated photochemical reactions

Huang, L. F., & Han, G. (2024) · Nature Reviews Chemistry · doi:10.1038/s41570-024-00585-3 · Cited by 112 · see citing works

Collagen-based biocomposites inspired by bone hierarchical structures for advanced bone regeneration: ongoing research and perspectives

Qin, D., Wang, N., You, X.-G., Zhang, A.-D., Chen, X., & Liu, Y. (2021) · Biomaterials Science · doi:10.1039/d1bm01294k · Cited by 111 · see citing works

The emerging role of nanotechnology in plant genetic engineering

Squire, H. J., Tomatz, S., Voke, E., Grandío, E. G., & Landry, M. P. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00037-5 · Cited by 110 · see citing works

In Vivo Self‐Assembly Induced Cell Membrane Phase Separation for Improved Peptide Drug Internalization

Guo, R., Zhang, X., Fan, P., Song, B., Li, Z., Duan, Z., Qiao, Z., & Wang, H. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202111839 · Cited by 109 · see citing works

Stimuli-Responsive Nanomedicines for the Treatment of Non-cancer Related Inflammatory Diseases

Yang, J., Rieux, A. D., & Malfanti, A. (2025) · ACS Nano · doi:10.1021/acsnano.5c00700 · Cited by 114 · see citing works

Overcoming barriers for intra-articular delivery of disease-modifying osteoarthritis drugs

Gao, J., Xia, Z. J., Baby, H. M., Joseph, J., Luo, J. N., & Joshi, N. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.12.004 · Cited by 108 · see citing works

Magnetically driven capsules with multimodal response and multifunctionality for biomedical applications

Sun, Y., Wang, Z., Gu, J., Xia, L., Cao, Y., Zhu, X., Wen, H., Ouyang, S., Liu, R., Li, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46046-9 · Cited by 107 · see citing works

MLCPP 2.0: An Updated Cell-penetrating Peptides and Their Uptake Efficiency Predictor

Manavalan, B., & Patra, M. C. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167604 · Cited by 105 · see citing works

Albumin-based delivery systems: Recent advances, challenges, and opportunities

Murphy, G., Brayden, D. J., Cheung, D. L., Liew, A., Fitzgerald, M. T., & Pandit, A. S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.035 · Cited by 105 · see citing works

Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems—A Pharmaceutical Perspective

Boczar, D., & Michalska, K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071389 · Cited by 104 · see citing works

Antibody-based drug delivery systems for cancer therapy: Mechanisms, challenges, and prospects

Chen, Z., Kankala, R. K., Yang, Z., Li, W., Xie, S., Li, H., Chen, A., & Zou, L. (2022) · Theranostics · doi:10.7150/thno.72594 · Cited by 104 · see citing works

Smart hydrogel: A new platform for cancer therapy

Li, G., Fu, Z.-M., Li, H., Wei, R., Guo, J., Wang, H., & Qi, J. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103470 · Cited by 99 · see citing works

Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control

Long, X., Liu, M., Nan, Y., Chen, Q., Xiao, Z., Xiang, Y., Ying, X., Sun, J., Huang, Q., & Ai, K. (2024) · Advanced Materials · doi:10.1002/adma.202308239 · Cited by 96 · see citing works

Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate

Sheikholeslami, B., Lam, N. W., Dua, K., & Haghi, M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120574 · Cited by 98 · see citing works

Transformative Impact of Nanocarrier‐Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons

Kim, M., Shin, M., Zhao, Y., Ghosh, M., & Son, Y. (2024) · Small Science · doi:10.1002/smsc.202400280 · Cited by 101 · see citing works

Sulfobutylether-β-cyclodextrin: A functional biopolymer for drug delivery applications

Pardeshi, C. V., Kothawade, R. V., Markad, A. R., Pardeshi, S. R., Kulkarni, A. D., Chaudhari, P. J., Longhi, M. R., Dhas, N. L., Naik, J., Surana, S. J., et al. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120347 · Cited by 92 · see citing works

Cellular landscaping of cisplatin resistance in cervical cancer

Bhattacharjee, R., Dey, T., Kumar, L., Kar, S., Sarkar, R., Ghorai, M., Malik, S., Jha, N. K., Vellingiri, B., Kesari, K. K., et al. (2022) · Biomedicine &amp; Pharmacotherapy · doi:10.1016/j.biopha.2022.113345 · Cited by 93 · see citing works

Regulatory safety evaluation of nanomedical products: key issues to refine

de Jong, W. H., Geertsma, R. E., & Borchard, G. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01208-4 · Cited by 90 · see citing works

Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer

Bottens, R. A., & Yamada, T. (2022) · Cancers · doi:10.3390/cancers14225546 · Cited by 90 · see citing works

Degrader–Antibody Conjugates: Emerging New Modality

Hong, K. B., & An, H. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01791 · Cited by 90 · see citing works

Advancement of Nanofibrous Mats and Common Useful Drug Delivery Applications

Owida, H. A., Al-Nabulsi, J., Alnaimat, F., Sharah, A. A., Al-Ayyad, M. S., Turab, N. M., & Abdullah, M. (2022) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/2022/9073837 · Cited by 88 · see citing works

Assessment of In Vitro Release Testing Methods for Colloidal Drug Carriers: The Lack of Standardized Protocols

Gómez-Lázaro, L., Martín‐Sabroso, C., Aparicio-Blanco, J., & Torres‐Suárez, A. I. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16010103 · Cited by 88 · see citing works

Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy

Dubey, A. K., & Mostafavi, E. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1259435 · Cited by 89 · see citing works

Liposomal Formulations: A Recent Update

Agrawal, S. S., Baliga, V., & Londhe, V. Y. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics17010036 · Cited by 91 · see citing works

Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy

Dogbey, D. M., Torres, V. E. S., Fajemisin, E. A., Mpondo, L., Ngwenya, T., Akinrinmade, O. A., Perriman, A. W., & Barth, S. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01362-3 · Cited by 91 · see citing works

Microrobots for Biomedicine: Unsolved Challenges and Opportunities for Translation

Lee, J. G., Raj, R. R., Day, N. B., & Shields, C. W. (2023) · ACS Nano · doi:10.1021/acsnano.3c03723 · Cited by 85 · see citing works

Bioresponsive drug delivery systems

Alavi, S. E., Alharthi, S., Alavi, S. E., Raza, A., & Shahmabadi, H. E. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103849 · Cited by 85 · see citing works

Living Leukocyte‐Based Drug Delivery Systems

Chen, Y., Qin, D., Zou, J., Li, X., Guo, X. D., Tang, Y., Chuang, L. I. U., Chen, W., Kong, N., Zhang, C. Y., et al. (2022) · Advanced Materials · doi:10.1002/adma.202207787 · Cited by 85 · see citing works

Designing Covalent Organic Framework‐Based Light‐Driven Microswimmers toward Therapeutic Applications

Sridhar, V., Yıldız, E., Rodríguez‐Camargo, A., Lyu, X., Yao, L., Wrede, P., Aghakhani, A., Akolpoglu, M. B., Podjaski, F., Lotsch, B. V., et al. (2023) · Advanced Materials · doi:10.1002/adma.202301126 · Cited by 83 · see citing works

Molecular insights of exercise therapy in disease prevention and treatment

Walzik, D., Chirino, T. Y. W., Zimmer, P., & Joisten, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01841-0 · Cited by 89 · see citing works

Functionalization of luminescent lanthanide complexes for biomedical applications

Xian, T., Meng, Q. Y., Gao, F., Hu, M., & Wang, X. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214866 · Cited by 82 · see citing works

pH-responsive dual-functional hydrogel integrating localized delivery and anti-cancer activities for highly effective therapy in PDX of OSCC

Liu, T., Du, Y., Yan, Y., Song, S., Qi, J., Xia, X., Hu, X., Chen, Q., Liu, J., Zeng, X., et al. (2023) · Materials Today · doi:10.1016/j.mattod.2022.12.009 · Cited by 82 · see citing works

Exploring and Analyzing the Systemic Delivery Barriers for Nanoparticles

Wang, L., Quine, S., Frickenstein, A. N., Lee, M., Yang, W., Sheth, V. M., Bourlon, M. D., He, Y., Lyu, S., Garcia‐Contreras, L., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202308446 · Cited by 83 · see citing works

Advances in organic nano-architectures based on NIR-II small-molecule fluorophores for biomedical imaging and therapy

Bian, H., Ma, D., Nan, Y., Kim, M. H., Kim, S. H., Chen, X., Peng, X., & Yoon, J. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216551 · Cited by 82 · see citing works

Advancing drug delivery to articular cartilage: From single to multiple strategies

Zhao, T., Li, X., Li, H., Deng, H., Li, J., Yang, Z., He, S., Jiang, S., Sui, X., Guo, Q., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.11.021 · Cited by 80 · see citing works

Engineered Cell Membrane Coating Technologies for Biomedical Applications: From Nanoscale to Macroscale

An, Y., Ji, C., Zhang, H., Jiang, Q., Maitz, M. F., Pan, J., Luo, R., & Wang, Y. (2025) · ACS Nano · doi:10.1021/acsnano.4c16280 · Cited by 82 · see citing works

Stimuli‐Responsive Silica Silanol Conjugates: Strategic Nanoarchitectonics in Targeted Drug Delivery

Mohanan, S., Guan, X., Liang, M., Karakoti, A. S., & Vinu, A. (2023) · Small · doi:10.1002/smll.202301113 · Cited by 80 · see citing works

Emerging delivery approaches for targeted pulmonary fibrosis treatment

Diwan, R., Bhatt, H., Beaven, E., & Nurunnabi, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115147 · Cited by 78 · see citing works

Biodegradable Materials for Transient Organic Transistors

Stephen, M., Nawaz, A., Lee, S. Y., Sonar, P. M., & Leong, W. L. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202208521 · Cited by 76 · see citing works

Photoresponsive Drug Delivery Systems: Challenges and Progress

Yang, Y., Long, K., Chu, Y., Lu, H., Wang, W., & Zhan, C. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202402975 · Cited by 75 · see citing works

Additive manufacturing in drug delivery: Innovative drug product design and opportunities for industrial application

Ragelle, H., Rahimian, S., Guzzi, E. A., Westenskow, P. D., Tibbitt, M. W., Schwach, G., & Langer, R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113990 · Cited by 72 · see citing works

Biomaterials Based on Organic Polymers and Layered Double Hydroxides Nanocomposites: Drug Delivery and Tissue Engineering

Constantino, V. R. L., Figueiredo, M. P., Magri, V. R., Eulálio, D., Cunha, V. R. R., Alcântara, A. C. S., & Perotti, G. F. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020413 · Cited by 73 · see citing works

Cell–drug conjugates

Wang, Y., Shi, J., Xin, M., Kahkoska, A. R., Wang, J., & Gu, Z. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01230-6 · Cited by 81 · see citing works

From Nature‐Sourced Polysaccharide Particles to Advanced Functional Materials

Ma, Y., Morozova, S. M., & Kumacheva, E. (2024) · Advanced Materials · doi:10.1002/adma.202312707 · Cited by 72 · see citing works

Innovative transdermal drug delivery systems: Benefits, challenges, and emerging application

Shah, S. W. A., Li, X., Yuan, H., Shen, H., Quan, S., Pan, G., Ishfaq, M., Shah, A. U., Xie, H., & Shao, J. (2025) · BMEMat · doi:10.1002/bmm2.70001 · Cited by 72 · see citing works

Amelioration of systemic antitumor immune responses in cocktail therapy by immunomodulatory nanozymes

Wang, S., Wang, Z., Li, Z., Zhang, X., Zhang, H., Zhang, T., Meng, X., Sheng, F., & Hou, Y. (2022) · Science Advances · doi:10.1126/sciadv.abn3883 · Cited by 71 · see citing works

Delivering living medicines with biomaterials

Harimoto, T., Jung, W., & Mooney, D. J. (2025) · Nature Reviews Materials · doi:10.1038/s41578-024-00766-y · Cited by 72 · see citing works

Transcriptome Analysis Revealed the Symbiosis Niche of 3D Scaffolds to Accelerate Bone Defect Healing

Ji, C., Qiu, M., Ruan, H., Li, C., Cheng, L., Wang, J., Li, C., Jin, Q., Cui, W., & Deng, L. (2022) · Advanced Science · doi:10.1002/advs.202105194 · Cited by 69 · see citing works

Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury

Liu, M., Huang, Q., Zhu, Y., Chen, L., Li, Y., Gong, Z., & Ai, K. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100215 · Cited by 69 · see citing works

Lipid Nanoparticles: A Novel Gene Delivery Technique for Clinical Application

Mashima, R., & Takada, S. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100341 · Cited by 68 · see citing works

Trends in Drug Delivery Systems for Natural Bioactive Molecules to Treat Health Disorders: The Importance of Nano-Liposomes

Cardoso, R. V., Pereira, P. R., Freitas, C. S., & Paschoalin, V. M. F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122808 · Cited by 69 · see citing works

Nanocarriers for oral delivery of biologics: small carriers for big payloads

Cao, Y., Rewatkar, P. V., Wang, R., Hasnain, S. Z., Popat, A., & Kumeria, T. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.08.005 · Cited by 68 · see citing works

The Evolution of 5 Therapeutic Drug Delivery Technologies

Fang, S. J. (2021) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.5162156

The Future of Drug Delivery

Gao, J., Karp, J. M., Langer, R., & Joshi, N. (2023) · Chemistry of Materials · doi:10.1021/acs.chemmater.2c03003 · Cited by 283 · see citing works

Introduction

(2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26787-1.00001-1

Insight on the Rise and Raise of Drug Delivery with Special Emphasis on Five Classes of Therapeutics

Desavathu, M., Singh, P., Pal, A., Joshi, N., & Upadhyay, R. K. (2025) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2025053703 · Cited by 1 · see citing works

A Review of Next-Generation Drug Delivery Systems And Technologies

Sahithi, C., & Ande, P. P. (2023) · International Journal of Research in Pharmacology & Pharmacotherapeutics · doi:10.61096/ijrpp.v12.iss4.2023.289-300